Showing results (21-30 of 162) with videos related to

Sort By:
Pageof 17
Expert Review of Hematology|June 3, 2016
Paving the way for new agents; is standard chemotherapy part of the treatment paradigm for chronic lymphocytic leukemia in the future?Anna Maria Frustaci, Marco Montillo, Paola Picardi, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 28, 2026
Chronic Lymphocytic Leukemia Through the Spectrum: Frontline Therapy, Sequencing With Subsequent Therapy, and Treatment of Double-Refractory PatientsAnna Maria Frustaci, Alessandra Tedeschi, Alexander F Vom Stein, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 31, 2021
SOHO State of the Art Updates and Next Questions: What is Fitness in the Era of Targeted Agents?Anna Maria Frustaci, Marina Deodato, Giulia Zamprogna, et al.
Expert Review of Hematology|March 28, 2019
Ibrutinib for the treatment of chronic lymphocytic leukemiaMarina Deodato, Anna Maria Frustaci, Giulia Zamprogna, et al.
Cancers|March 11, 2023
Next Generation BTK Inhibitors in CLL: Evolving Challenges and New OpportunitiesAnna Maria Frustaci, Marina Deodato, Giulia Zamprogna, et al.
Future Oncology (London, England)|December 16, 2017
Ibrutinib and its use in the treatment of chronic lymphocytic leukemiaAnna Maria Frustaci, Alessandra Tedeschi, Marina Deodato, et al.
Therapeutic Advances in Hematology|August 6, 2016
Ofatumumab plus chlorambucil as a first-line therapy in less fit patients with chronic lymphocytic leukemia: analysis of COMPLEMENT1 and other monoclonal antibodies association dataAnna Maria Frustaci, Alessandra Tedeschi, Paola Picardi, et al.
Expert Opinion on Pharmacotherapy|April 16, 2020
Duvelisib for the treatment of chronic lymphocytic leukemiaAnna Maria Frustaci, Alessandra Tedeschi, Marina Deodato, et al.
Frontiers in Microbiology|May 14, 2019
HTLV-1 HBZ Protein Resides Exclusively in the Cytoplasm of Infected Cells in Asymptomatic Carriers and HAM/TSP PatientsGreta Forlani, Marco Baratella, Alessandra Tedeschi, et al.
Hematological Oncology|February 16, 2024
Identifying and addressing unmet clinical needs on the use of zanubrutinib in chronic lymphocytic leukemia: A consensus-based position paper from an ad hoc expert panelFrancesca Romana Mauro, Alessandra Tedeschi, Marzia Varettoni, et al.
Pageof 17